TickerFactsScreenerDevelopers

Nuo Therapeutics, Inc. (AURX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2013: $3.29M2014: $15.95M2015: $922.3K2016: $2.62M2017: $693.5K2018: $636.9K2019: $20.3K2020: $161.4K2021: $1.41M2022: $2.05M2023: $928.7K2024: $283.7K2025: $548.9K$548.9K
2013Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$548.9K+93.5%
2024$283.7K-69.4%
2023$928.7K-54.7%
2022$2.05M+45.0%
2021$1.41M+776.3%
2020$161.4K+697.1%
2019$20.3K-96.8%
2018$636.9K-8.2%
2017$693.5K-73.5%
2016$2.62M+184.1%
2015$922.3K-94.2%
2014$15.95M+385.2%
2013$3.29M—